Statistics/Trends

This report presents data on the impact of chlamydia, gonorrhea, syphilis, and genital herpes on 10-19 year olds in Arizona for 2009. The data were derived from the Arizona Department of Health Services STD Surveillance Database. The data are presented by race/ethnicity, county, and gender for each disease. It includes certain populations such as young adults in juvenile detention facilities. It is noted that chlamydia, gonorrhea, and herpes are more frequently diagnosed in young females than in young males.

This report summarizes CDC’s National HIV Behavioral Surveillance System (NHBS) data collected in 2008 from 21 metropolitan statistical areas (MSAs) using an anonymous cross-sectional interview of men at venues where men who have sex with men (MSM) congregate. The data show that of 8,153 MSM interviewed and tested in the 21 MSAs participating in NHBS in 2008, HIV prevalence was 19 percent, with non-Hispanic blacks having the highest prevalence (28 percent), followed by Hispanics (18 percent), non-Hispanic whites (16 percent), and persons who were multiracial or of other race (17 percent).

This report summarizes the results of a CDC analysis of recent trends in congenital syphilis (CS) rates, using national surveillance data from the years 2003-2008. Results show that after declining for 14 years, the CS rate among infants aged <1 year increased 23 percent, from 8.2 cases per 100,000 live births in 2005 to 10.1 during 2008. The increase followed a 38 percent increase in primary and secondary syphilis rate among females aged =10 years from 2004-2007.

The Centers for Disease Control and Prevention (CDC) analyzed serologic test results from persons aged 14-49 years who participated in the National Health and Nutrition Examination Survey (NHANES) 2005-2008, to determine whether HSV-2 seroprevalence in the United States has changed since 1999-2004. CDC also used the data to estimate HSV-2 seroprevalence by age, race/ethnicity, and reported lifetime number of sex partners. Results indicated that HSV-2 seroprevalence was 16.2 percent overall, not statistically different from that of 1999-2004, and was highest among women and non-Hispanic blacks.

This report describes the most recent trends in diagnoses of perinatal HIV infection by race/ethnicity, by summarizing results of analyses of national surveillance data from 34 states from 2004-2007. During 2004-2007, 85 percent of diagnoses of perinatal HIV were in blacks or African Americans (69 percent) or Hispanics or Latinos (16 percent). The average annual rate of diagnoses of perinatal HIV during that time was 12.3 per 100,000 among blacks, 2.1 per 100,000 among Hispanics, and 0.5 per 100,000 among whites.

This report present statistics and trends for sexually transmitted diseases (STDs) in the United States through 2009. The information is based on (1) data from notifiable disease reporting from state and local STD programs; (2) projects that monitor STD prevalence in various settings, including Regional Infertility Prevention projects, the National Job Training Program, the Indian Health Service, the STD Surveillance Network, and the Gonococcal Isolate Surveillance Project; and (3) National surveys implemented by federal and private organizations.

This report summarizes results of an analysis of District of Columbia (DC) HIV case surveillance data, HIV testing data, and data from the Behavioral Risk Factor Surveillance System to describe recent trends in HIV disease and testing. The DC Department of Health used HIV case surveillance data for residents of DC reported through December 31, 2009 to determine the number and percentage of adolescents and adults aged>12 years newly diagnosed with AIDS 2004-2008, overall and by race/ethnicity and sex.

This report summarizes results of the California Department of Public Health (CDPH) Adult Hepatitis Vaccine Project (AHVP) for 2007-2008, in response to the CDC national initiative encouraging states to use existing federal funds to purchase adult hepatitis B vaccine. Data show that 28,824 doses of Hepatitis B vaccine were administered at 29 participating sites in the first 19 months of the AHVP, and 13 sites administered the vaccine for the first time.

This report provides the most recent population-based estimates of hepatocellular cancer (HCC) incidence rates and trends in the United States. The report summarizes the results of CDC analysis of data for the period 2001-2006 from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology, and End Results surveillance system, to determine trends in HCC incidence. Results determined that average annual incidence rate of HCC for 2001-2006 was 3.0 per 100,000 persons and increased from 2.7 per 100,000 in 2001 to 3.2 in 2006.

This report calculates the estimated lifetime risk (ELR) and age-conditional risk for diagnosis of HIV infection among Hispanics/Latinos in 37 states and Puerto Rico. The CDC analyzed HIV surveillance data, vital statistics data on general and HIV-specific mortality, and US Census data from 2007. Results indicate that an estimated 1.92 percent (one in 52) Hispanics/Latinos would be diagnosed with HIV during their lifetimes, compared with an ELR of .59 percent (one in 170) for whites, and 4.65 percent (one in 22) for blacks/African Americans.